Drugs / Estradiol/Norethindrone Acetate
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02654054 | Dec 2015 → Jan 2018 | uterine benign neoplasm | AbbVie | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Estradiol/Norethindrone Acetate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02654054 ↗ |